FindTrial
Sign In

new index for assessment of Insulin Resistance in Metabolic syndrome patients

A Validation of SINGLE POINT INSULIN SENSITIVITY ESTIMATOR(SPISE) with HOMA-IR in Metabolic syndrome- A study in south Indian population - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/01/079387
Enrollment
150
Registered
2025-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SPISE index: Single Point Insulin Sensitivity Estimator

Sponsors

Department of Endocrinology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: cases who are diagnosed as metabolic syndrome according to south asian modified -NCEP criteria

Exclusion criteria

Exclusion criteria: cushings syndrome, hypothyroidism, secondary hypertension, type 1 diabetes mellitus, hepatobiliary disease, nephritic syndrome, pregnancy

Design outcomes

Primary

MeasureTime frame
Measurement of SPISE and comparison with HOMA-IRTimepoint: Baseline—

Secondary

MeasureTime frame
to define a cut off for SPISE in South Indian populationTimepoint: Baseline—

Countries

India

Contacts

Public ContactSreekumar P S

Madurai Medical college

subbiahegappan@gmail.com9842172001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026